Login to Your Account

Alexza Reports Another Positive Study of its Inhaled Antipsychotic

By Catherine Hollingsworth

Thursday, December 11, 2008
Alexza Pharmaceuticals Inc. said that a second Phase III study of its inhaled antipsychotic for agitated bipolar patients hit the mark, but the product still has to clear some safety studies. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription